Delivery Order SPE2DB22D1106-SPE2DB24FEJB7
Award Date 4/1/24
Potential Completion Date 4/2/24
Potential Value $10K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the Defense Logistics Agency (DLA). The $17,414.44 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 14, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML pharmaceutical products to the Defense Logistics Agency (DLA). The award, valued at $10,861.95, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed price, and the ultimate completion date is September 28, 2023. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. The $10,843.63 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of August 9, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,338.72 firm fixed price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,230.33 firm fixed-price delivery order is for the medical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has an ultimate completion date of December 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $4,647.12 to provide MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. This delivery order was issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, that serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $4,647.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,288,309 units of MONOVISC 88 MG/4 ML SYRINGE 4ML. This contract has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML. The $2,875.94 firm fixed-price delivery order contract has an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,647.12 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a period of performance through May 31, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
- The federal contract award described is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the Defense Logistics Agency (DLA). The $10,850.70 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order contract has an ultimate completion date of April 17, 2023 and was awarded on April 15, 2023. The contract is not designated with any set-aside requirements, indicating open competition....